Novo Nordisk A/S News Headlines

NVO 
$45.53
*  
0.10
0.22%
Get NVO Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Update on Lilly's Tabalumab - Analyst Blog
2/11/2013 5:40:01 PM - Zacks.com

Novo Nordisk Shares Tumble on FDA Letter
2/11/2013 9:59:00 AM - Fox Business

The FDA Throws Novo Nordisk Off Course
2/11/2013 9:25:00 AM - Seeking Alpha

Generics Continue to Hurt Sanofi - Analyst Blog
2/8/2013 1:20:01 PM - Zacks.com

Sanofi's Diabetes Drug Gets EU Nod - Analyst Blog
2/7/2013 5:44:31 PM - Zacks.com

Favorable Ruling for Pfizer - Analyst Blog
2/7/2013 5:00:01 PM - Zacks.com

Glaxo Bottom Line Misses Again - Analyst Blog
2/7/2013 1:20:01 PM - Zacks.com

SNY/REGN's Zaltrap Approved in EU - Analyst Blog
2/6/2013 5:45:08 PM - Zacks.com

AGN Earnings Miss but Guidance Tops - Analyst Blog
2/5/2013 5:28:01 PM - Zacks.com

SHPG Reaches Agreement with US Govt - Analyst Blog
2/5/2013 1:20:01 PM - Zacks.com

AbbVie Provides 2013 Outlook - Analyst Blog
2/4/2013 6:20:01 PM - Zacks.com

Generics Hurt AZN Results - Analyst Blog
2/4/2013 10:20:01 AM - Zacks.com

Roche Grows in 2012 - Analyst Blog
2/1/2013 3:15:01 PM - Zacks.com

Strong 2012 Results at Novo Nordisk - Analyst Blog
2/1/2013 11:00:01 AM - Zacks.com

Merck Beats, Issues Outlook - Analyst Blog
2/1/2013 10:10:01 AM - Zacks.com

Generex: Research For Sale On The Cheap
1/31/2013 3:16:00 AM - Seeking Alpha

Eli Lilly May Have The Best Chance At Keeping The Momentum Going
1/30/2013 3:22:00 PM - Seeking Alpha

Roche Teams Up With Afraxis - Analyst Blog
1/30/2013 1:50:01 PM - Zacks.com

Merck's OAB Patch Gets FDA Nod - Analyst Blog
1/28/2013 4:41:01 PM - Zacks.com

FDA Approves Novartis' Exjade - Analyst Blog
1/25/2013 2:10:01 PM - Zacks.com

Novartis Beats on Revs, EPS In-Line - Analyst Blog
1/24/2013 2:15:30 PM - Zacks.com

EU Nod for Novo Nordisk Drugs - Analyst Blog
1/23/2013 7:14:12 PM - Zacks.com

Dividend Contenders: 30 Increases Expected By The End Of March
1/18/2013 7:03:00 AM - Seeking Alpha

These 2 "Goodwill Stocks" Could Help More Than 366 Million People
1/17/2013 12:00:00 PM - StreetAuthority

Acorda Provides Guidance - Analyst Blog
1/8/2013 7:45:01 PM - Zacks.com